Health News (Reuters)

Long-term safety of silicone breast implants still unclear

(Reuters Health) - Women with silicone breast implants may have a higher risk of certain medical problems than women who don't get implants, but more research is needed to get a complete picture of implant safety over the long term, a new U.S. study suggests.

Fitness trackers' accuracy varies widely for calories burned

(Reuters Health) - Even though many people swear by fitness trackers to help lose weight and stay in shape, a review of existing research confirms that many of these gadgets are not very good at measuring how much energy we burn.

French foie gras makers say they are ready if bird flu returns

French foie gras makers, still recovering from two severe bird flu crises that ravaged flocks, said on Thursday they would be able to face any new outbreak thanks to strict security measures but prices will remain high to make up for increased costs.

AbbVie settles Humira biosimilar dispute with Fresenius Kabi

U.S. drugmaker AbbVie Inc said on Thursday it has settled a patent dispute regarding its Humira biosimilar with Fresenius Kabi Oncology Ltd and will grant the Germany-based company non-exclusive marketing rights for the drug.

IUD risk for new mothers depends on timing

(Reuters Health) - New mothers who want intrauterine devices (IUDs) for long-acting contraception after giving birth should know the risk of the implant being expelled is tied to how soon after delivery it is inserted, researchers say.

McConnell says Senate Republicans might revisit Obamacare repeal

Republicans could try again to repeal Obamacare if they win enough seats in U.S. elections next month, Senate Republican Leader Mitch McConnell said on Wednesday, calling a failed 2017 push to repeal the healthcare law a "disappointment."

Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

Express Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

Pages